ClinicalTrials.Veeva

Menu

Influence of Vibroacoustic Therapy Modes on the Course of Coronavirus Infection

A

Astana Medical University

Status

Completed

Conditions

COVID-19
Vibration; Exposure
Acute Respiratory Failure

Treatments

Device: Vibrolung

Study type

Interventional

Funder types

Other

Identifiers

NCT05143372
СТЛ-000215

Details and patient eligibility

About

Assessment of the dynamics of changes in physical, instrumental and laboratory parameters in patients with identified coronavirus infection complicated by acute respiratory failure included in the study in accordance with the inclusion criteria, and comparison of the results with the control group, study of the effect of modes when using vibroacoustic lung therapy.

Enrollment

60 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • adults
  • P/F less 300 torr
  • COVID-19 Virus Infection

Exclusion criteria

  • children
  • acute stroke
  • acute coronary syndrome
  • DVT
  • implanted pacemaker
  • rib fracture
  • infection on chest

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

60 participants in 2 patient groups

SaO2 (oxygen status)
Active Comparator group
Description:
Measurment 4 times per day, ABA (acid-bases analyses)
Treatment:
Device: Vibrolung
PaO2/FiO2 (respiratory index)
Active Comparator group
Description:
Measurment 4 times per day, ABA (acid-bases analyses)
Treatment:
Device: Vibrolung

Trial contacts and locations

3

Loading...

Central trial contact

Aidos Konkayev

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems